The nation of Zimbabwe has declined a significant American healthcare agreement worth $367m (272 million pounds) over five years because of Washington's demand for confidential biological samples.
This rejection became public after a government memo dated December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government representative has since stated that the United States was requesting genetic material for scientific study and commercial gain while was not willing to share the resulting advantages from any future medical innovations.
"We are forced to start the difficult and regrettable task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for continued talks to find a deal acceptable to all parties so the nation's critical HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision follows a similar situation in Kenya, where a court suspended a similar deal with the US after concerns were raised about the security of citizens' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and accountability.
According to statements, 16 nations in Africa have to date signed these new health pacts, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no equivalent promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Effectively, our country would supply the basic resources for medical research with no assurance that the final treatments would be available to our citizens if a future disease outbreak arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining structures already set up via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.
"This framework is intended to ensure that when a country provides its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our US partners on how future co-operation might be structured in a way that honours the independence and dignity of both nations."
Health Experts Response
Medical experts expressed it recognised the official position, but recommended that negotiations should continue given that a large portion of the nation's HIV programmes were funded by international support.
"In cases where technical issues exist, including those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," the group said.
The halted deal emphasises the ongoing debate between receiving vital foreign assistance and safeguarding local interests in an increasingly interconnected world.